Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History HDRPF

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics HDRPF

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – AUD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Epsilon Healthcare Ltd

HDRPF
Current price
0.0014 USD 0 USD (0.00%)
Last closed 0.024 AUD
ISIN AU0000137598
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange AU
Capitalization 7 136 306 AUD
Yield for 12 month 0.00 %
1Y
3Y
5Y
10Y
15Y
HDRPF
21.11.2021 - 28.11.2021

Epsilon Healthcare Limited operates as a healthcare and pharmaceuticals company primarily in Australia and Canada. It engages in the manufacture and distribution of hydroponics equipment, materials, and nutrients; and development and delivery of medicinal cannabis, as well as provides turnkey cannabis cultivation solutions. The company was formerly known as THC Global Group Limited and changed its name to Epsilon Healthcare Limited in February 2021. Epsilon Healthcare Limited was incorporated in 2016 and is based in Sydney, Australia. Address: 9 Castlereagh Street, Sydney, NSW, Australia, 2000

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

P/E Ratio

Dividend Yield

Financials HDRPF

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures HDRPF

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

+6 584 909 AUD

Last Year

+7 040 969 AUD

Current Quarter

+3 307 259 AUD

Last Quarter

+1 638 825 AUD

Current Year

+4 763 741 AUD

Last Year

-3 062 655 AUD

Current Quarter

+859 087 AUD

Last Quarter

+1 151 620 AUD
EBITDA -3 592 226 AUD
Operating Margin TTM -20.48 %
Price to Earnings
Return On Assets TTM -19.25 %
PEG Ratio
Return On Equity TTM -60.10 %
Wall Street Target Price
Revenue TTM 7 140 541 AUD
Book Value 0.031 AUD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 3.10 %
Dividend Yield
Gross Profit TTM 1 232 321 AUD
Earnings per share -0.0099 AUD
Diluted Eps TTM -0.0099 AUD
Most Recent Quarter II 2023
Quarterly Earnings Growth YOY
Profit Margin -82.17 %

Stock Valuation HDRPF

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 1.34
Price Sales TTM 1.00
Enterprise Value EBITDA -3.02
Price Book MRQ 0.79

Technical Indicators HDRPF

For 52 Weeks

0.024 AUD 0.024 AUD
50 Day MA 0.024 AUD
Shares Short Prior Month
200 Day MA 0.025 AUD
Short Ratio
Shares Short
Short Percent